taurine has been researched along with Diabetic Glomerulosclerosis in 23 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine is a well documented antioxidant agent." | 5.35 | Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells. ( Chuang, LY; Guh, JY; Hsu, MS; Huang, JS; Yang, YL, 2008) |
| "Taurine is an amino acid that has pleiotropic protective properties on some diseases." | 2.82 | A systematic review of preclinical studies on the taurine role during diabetic nephropathy: focused on anti-oxidative, anti-inflammation, and anti-apoptotic effects. ( Jia, S; Ma, J; Yang, R; Yang, Z, 2022) |
| "Taurine is a semi-essential amino acid in mammals and has been shown to be a potent endogenous antioxidant." | 1.72 | Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats. ( Li, S; Piao, F; Wang, D; Zhang, C; Zhang, M, 2022) |
| "Taurine was administered orally for 3 weeks (1% w/v in drinking water) either from the day on which alloxan was injected or after the onset of diabetes." | 1.38 | Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. ( Das, J; Sil, PC, 2012) |
| "Taurine could lower blood glucose, TG, TC, BUN, Scr, NAG, U-PRO, the expression of laminin B1(LBN1) mRNA, and increase HDL-C of diabetic rats." | 1.36 | Preventive effect of taurine on experimental type II diabetic nephropathy. ( Hu, J; Lin, S; Liu, M; Luan, X; Lv, Q; Wu, G; Yang, J; Zhao, H, 2010) |
| "Taurine is a well documented antioxidant agent." | 1.35 | Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells. ( Chuang, LY; Guh, JY; Hsu, MS; Huang, JS; Yang, YL, 2008) |
| "Taurine was administered to diabetic rats from 2 days to 4 weeks after streptozotocin injection." | 1.33 | Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. ( Ha, H; Jiang, Z; Kwon, MK; Lee, EA; Lee, HB; Seo, JY; Yu, MR, 2005) |
| " Chronic administration of melatonin (n = 6) and taurine (n = 6) prevented increases in glomerular TGF-beta1 and fibronectin mRNAs and proteinuria without having effect on blood glucose." | 1.30 | Melatonin and taurine reduce early glomerulopathy in diabetic rats. ( Ha, H; Kim, KH; Yu, MR, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 6 (26.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J | 1 |
| Yang, Z | 1 |
| Jia, S | 1 |
| Yang, R | 1 |
| Li, S | 2 |
| Wang, D | 1 |
| Zhang, M | 2 |
| Zhang, C | 2 |
| Piao, F | 2 |
| Ural, C | 1 |
| Celik, A | 1 |
| Ozbal, S | 1 |
| Guneli, E | 1 |
| Arslan, S | 1 |
| Ergur, BU | 1 |
| Cavdar, C | 1 |
| Akdoğan, G | 1 |
| Cavdar, Z | 1 |
| Zhang, R | 1 |
| Wang, X | 1 |
| Gao, Q | 1 |
| Jiang, H | 1 |
| Zhang, S | 1 |
| Lu, M | 1 |
| Liu, F | 1 |
| Xue, X | 1 |
| Shi, X | 1 |
| Luo, M | 1 |
| Lan, Q | 1 |
| Ullah, H | 1 |
| Chen, X | 1 |
| Wang, Y | 2 |
| Meng, D | 1 |
| Wu, L | 1 |
| Li, Z | 1 |
| Ma, X | 1 |
| Zhao, S | 1 |
| Zhao, D | 1 |
| Qin, G | 1 |
| Han, X | 1 |
| Ito, T | 1 |
| Azuma, J | 1 |
| Schaffer, SW | 1 |
| Chesney, RW | 1 |
| Pandya, KG | 2 |
| Budhram, R | 2 |
| Clark, GJ | 1 |
| Lau-Cam, CA | 2 |
| Higo, S | 1 |
| Miyata, S | 1 |
| Jiang, QY | 1 |
| Kitazawa, R | 1 |
| Kitazawa, S | 1 |
| Kasuga, M | 1 |
| Wang, L | 1 |
| Zhang, L | 1 |
| Yu, Y | 1 |
| Niu, N | 1 |
| Huang, JS | 1 |
| Chuang, LY | 1 |
| Guh, JY | 1 |
| Yang, YL | 1 |
| Hsu, MS | 1 |
| Winiarska, K | 1 |
| Szymanski, K | 1 |
| Gorniak, P | 1 |
| Dudziak, M | 1 |
| Bryla, J | 1 |
| Lin, S | 1 |
| Yang, J | 1 |
| Wu, G | 1 |
| Liu, M | 1 |
| Luan, X | 1 |
| Lv, Q | 1 |
| Zhao, H | 1 |
| Hu, J | 1 |
| Das, J | 1 |
| Sil, PC | 1 |
| Clark, G | 1 |
| Lee, EA | 1 |
| Seo, JY | 1 |
| Jiang, Z | 1 |
| Yu, MR | 2 |
| Kwon, MK | 1 |
| Ha, H | 2 |
| Lee, HB | 1 |
| Furfaro, AL | 1 |
| Menini, S | 1 |
| Patriarca, S | 1 |
| Pesce, C | 1 |
| Odetti, P | 1 |
| Cottalasso, D | 1 |
| Marinari, UM | 1 |
| Pronzato, MA | 1 |
| Traverso, N | 1 |
| Trachtman, H | 2 |
| Futterweit, S | 1 |
| Maesaka, J | 1 |
| Ma, C | 1 |
| Valderrama, E | 1 |
| Fuchs, A | 1 |
| Tarectecan, AA | 1 |
| Rao, PS | 1 |
| Sturman, JA | 2 |
| Boles, TH | 1 |
| Kim, KH | 1 |
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Suzuki, S | 1 |
| Shimada, N | 1 |
| Ohmuro, H | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
| Park, SH | 1 |
| Choi, HJ | 1 |
| Lee, JH | 1 |
| Woo, CH | 1 |
| Kim, JH | 1 |
| Han, HJ | 1 |
| De Lorenzi, F | 1 |
2 reviews available for taurine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
A systematic review of preclinical studies on the taurine role during diabetic nephropathy: focused on anti-oxidative, anti-inflammation, and anti-apoptotic effects.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Diabetes Mellitus; Diabetic Nephropathies; Humans | 2022 |
Taurine and experimental kidney disease.
Topics: Animals; Cell Division; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Kidney Diseases; | 1994 |
21 other studies available for taurine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Diabetes Mellitus, Experimenta | 2022 |
The renoprotective effects of taurine against diabetic nephropathy via the p38 MAPK and TGF-β/Smad2/3 signaling pathways.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Kid | 2023 |
Taurine Supplementation Reverses Diabetes-Induced Podocytes Injury via Modulation of the CSE/TRPC6 Axis and Improvement of Mitochondrial Function.
Topics: Animals; Apoptosis; Calcium; Cells, Cultured; Cystathionine gamma-Lyase; Diabetes Mellitus, Experime | 2020 |
Taurine ameliorates axonal damage in sciatic nerve of diabetic rats and high glucose exposed DRG neuron by PI3K/Akt/mTOR-dependent pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ganglia, Spinal; In | 2021 |
LncRNA TUG1 ameliorates diabetic nephropathy via inhibition of PU.1/RTN1 signaling pathway.
Topics: Animals; Apoptosis; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Mice; Nerve Tis | 2022 |
The quest for an animal model of diabetic nephropathy and the role of taurine deficiency.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Female; Hu | 2015 |
Taurine can enhance the protective actions of metformin against diabetes-induced alterations adversely affecting renal function.
Topics: Animals; Blood Glucose; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dru | 2015 |
Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Biomarkers; Blood Glucose; Body Weight; Deoxyguanosine; Diabet | 2008 |
The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Intercellular Adhesion Molecule-1; | 2008 |
Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells.
Topics: Animals; Antioxidants; Cell Cycle; Cell Proliferation; Collagen Type IV; Cyclin-Dependent Kinase Inh | 2008 |
Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Catalase; Creatinine; Diabetes Mellitus, Experime | 2009 |
Preventive effect of taurine on experimental type II diabetic nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephrop | 2010 |
Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
Topics: Administration, Oral; Albumins; Alloxan; Animals; Antioxidants; Apoptosis; Blood Glucose; Blood Urea | 2012 |
Comparative evaluation of taurine and thiotaurine as protectants against diabetes-induced nephropathy in a rat model.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Disease Models, Ani | 2013 |
Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Topics: Animals; Antioxidants; Base Sequence; Buthionine Sulfoximine; Cells, Cultured; Diabetes Mellitus, Ex | 2005 |
HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin.
Topics: Acetylcysteine; Aldehydes; Animals; Apoptosis; Cell Division; Diabetes Mellitus, Experimental; Diabe | 2005 |
Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats.
Topics: Animals; Chronic Disease; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycati | 1995 |
Melatonin and taurine reduce early glomerulopathy in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diures | 1999 |
Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy.
Topics: Albuminuria; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Matrix Metalloprot | 1999 |
High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-beta 1.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Cycle; Cell Division; Cells, Cultured; Diabetic Nephropa | 2001 |
[Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
Topics: Adult; Aged; Arteriosclerosis; Biliary Tract Diseases; Carbohydrate Metabolism; Coronary Disease; Di | 1971 |